Cargando…

Novel mRNA-containing cytoplasmic granules in ALK-transformed cells

In mammalian cells, nontranslating messenger RNAs (mRNAs) are concentrated in different cytoplasmic foci, such as processing bodies (PBs) and stress granules (SGs), where they are either degraded or stored. In the present study, we have thoroughly characterized cytoplasmic foci, hereafter called AGs...

Descripción completa

Detalles Bibliográficos
Autores principales: Fawal, Mohamad, Jean-Jean, Olivier, Vanzo, Nathalie, Morello, Dominique
Formato: Texto
Lenguaje:English
Publicado: The American Society for Cell Biology 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057698/
https://www.ncbi.nlm.nih.gov/pubmed/21233286
http://dx.doi.org/10.1091/mbc.E10-07-0569
_version_ 1782200303078080512
author Fawal, Mohamad
Jean-Jean, Olivier
Vanzo, Nathalie
Morello, Dominique
author_facet Fawal, Mohamad
Jean-Jean, Olivier
Vanzo, Nathalie
Morello, Dominique
author_sort Fawal, Mohamad
collection PubMed
description In mammalian cells, nontranslating messenger RNAs (mRNAs) are concentrated in different cytoplasmic foci, such as processing bodies (PBs) and stress granules (SGs), where they are either degraded or stored. In the present study, we have thoroughly characterized cytoplasmic foci, hereafter called AGs for ALK granules that form in transformed cells expressing the constitutively active anaplastic lymphoma kinase (ALK). AGs contain polyadenylated mRNAs and a unique combination of several RNA binding proteins that so far has not been described in mammalian foci, including AUF1, HuR, and the poly (A(+)) binding protein PABP. AGs shelter neither components of the mRNA degradation machinery present in PBs nor known markers of SGs, such as translation initiation factors or TIA/TIAR, showing that they are distinct from PBs or SGs. AGs and PBs, however, both move on microtubules with similar dynamics and frequently establish close contacts. In addition, in conditions in which mRNA metabolism is perturbed, AGs concentrate PB components with the noticeable exception of the 5′ to 3′ exonuclease XRN1. Altogether, we show that AGs constitute novel mRNA-containing cytoplasmic foci and we propose that they could protect translatable mRNAs from degradation, contributing thus to ALK-mediated oncogenicity.
format Text
id pubmed-3057698
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher The American Society for Cell Biology
record_format MEDLINE/PubMed
spelling pubmed-30576982011-05-30 Novel mRNA-containing cytoplasmic granules in ALK-transformed cells Fawal, Mohamad Jean-Jean, Olivier Vanzo, Nathalie Morello, Dominique Mol Biol Cell Articles In mammalian cells, nontranslating messenger RNAs (mRNAs) are concentrated in different cytoplasmic foci, such as processing bodies (PBs) and stress granules (SGs), where they are either degraded or stored. In the present study, we have thoroughly characterized cytoplasmic foci, hereafter called AGs for ALK granules that form in transformed cells expressing the constitutively active anaplastic lymphoma kinase (ALK). AGs contain polyadenylated mRNAs and a unique combination of several RNA binding proteins that so far has not been described in mammalian foci, including AUF1, HuR, and the poly (A(+)) binding protein PABP. AGs shelter neither components of the mRNA degradation machinery present in PBs nor known markers of SGs, such as translation initiation factors or TIA/TIAR, showing that they are distinct from PBs or SGs. AGs and PBs, however, both move on microtubules with similar dynamics and frequently establish close contacts. In addition, in conditions in which mRNA metabolism is perturbed, AGs concentrate PB components with the noticeable exception of the 5′ to 3′ exonuclease XRN1. Altogether, we show that AGs constitute novel mRNA-containing cytoplasmic foci and we propose that they could protect translatable mRNAs from degradation, contributing thus to ALK-mediated oncogenicity. The American Society for Cell Biology 2011-03-15 /pmc/articles/PMC3057698/ /pubmed/21233286 http://dx.doi.org/10.1091/mbc.E10-07-0569 Text en © 2011 Fawal et al. This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0). “ASCB®,“ “The American Society for Cell Biology®,” and “Molecular Biology of the Cell®” are registered trademarks of The American Society of Cell Biology.
spellingShingle Articles
Fawal, Mohamad
Jean-Jean, Olivier
Vanzo, Nathalie
Morello, Dominique
Novel mRNA-containing cytoplasmic granules in ALK-transformed cells
title Novel mRNA-containing cytoplasmic granules in ALK-transformed cells
title_full Novel mRNA-containing cytoplasmic granules in ALK-transformed cells
title_fullStr Novel mRNA-containing cytoplasmic granules in ALK-transformed cells
title_full_unstemmed Novel mRNA-containing cytoplasmic granules in ALK-transformed cells
title_short Novel mRNA-containing cytoplasmic granules in ALK-transformed cells
title_sort novel mrna-containing cytoplasmic granules in alk-transformed cells
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057698/
https://www.ncbi.nlm.nih.gov/pubmed/21233286
http://dx.doi.org/10.1091/mbc.E10-07-0569
work_keys_str_mv AT fawalmohamad novelmrnacontainingcytoplasmicgranulesinalktransformedcells
AT jeanjeanolivier novelmrnacontainingcytoplasmicgranulesinalktransformedcells
AT vanzonathalie novelmrnacontainingcytoplasmicgranulesinalktransformedcells
AT morellodominique novelmrnacontainingcytoplasmicgranulesinalktransformedcells